1,374
Views
189
CrossRef citations to date
0
Altmetric
Review

Genes associated with Alzheimer’s disease: an overview and current status

, &
Pages 665-681 | Published online: 17 May 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Saptadip Samanta, Sanjoy Chakraborty & Debasis Bagchi. (2023) Pathogenesis of Neurodegenerative Diseases and the Protective Role of Natural Bioactive Components. Journal of the American Nutrition Association 0:0, pages 1-13.
Read now
Trang Mai Tong, Thuy Thi Hong Dao, Loc Phuoc Doan, Dat Thanh Nguyen, Quynh-Tho Thi Nguyen, Thanh-Thuy Thi Do, Kiet Dinh Truong, Minh-Duy Phan, Hoai-Nghia Nguyen, Thang Cong Tran & Hoa Giang. (2022) Genetic analysis of Vietnamese patients with early-onset Alzheimer's disease. International Journal of Neuroscience 132:12, pages 1190-1197.
Read now
Nafaa Alzobaidi, Huma Quasimi, Nasr A Emad, Abdulsalam Alhalmi & Maaz Naqvi. (2021) Bioactive Compounds and Traditional Herbal Medicine: Promising Approaches for the Treatment of Dementia. Degenerative Neurological and Neuromuscular Disease 11, pages 1-14.
Read now
Mani Iyer Prasanth, Dicson Sheeja Malar, Tewin Tencomnao & James Michael Brimson. (2021) The emerging role of the sigma-1 receptor in autophagy: hand-in-hand targets for the treatment of Alzheimer’s. Expert Opinion on Therapeutic Targets 25:5, pages 401-414.
Read now

Articles from other publishers (184)

Yujiao Li, Jun Chang, Xi Chen, Jianwei Liu & Lan Zhao. (2023) Advances in the Study of APOE and Innate Immunity in Alzheimer’s Disease. Journal of Alzheimer's Disease, pages 1-16.
Crossref
Ashish Kumar, Yixin Su, Mitu Sharma, Sangeeta Singh, Susy Kim, Jeremy J. Peavey, Cynthia K. Suerken, Samuel N. Lockhart, Christopher T. Whitlow, Suzanne Craft, Timothy M. Hughes & Gagan Deep. (2023) MicroRNA expression in extracellular vesicles as a novel blood‐based biomarker for Alzheimer's disease. Alzheimer's & Dementia.
Crossref
Shaista Chaudhary & Dipak K. Sarkar. (2023) Fetal alcohol exposure impairs learning and memory functions and elevates levels of various biochemical markers of Alzheimer's disease in the brain of 12‐month‐old rats. Alcohol: Clinical and Experimental Research.
Crossref
Anna Bonaterra-Pastra, Sònia Benítez, Olalla Pancorbo, David Rodríguez-Luna, Carla Vert, Alex Rovira, M. Mar Freijo, Silvia Tur, Maite Martínez-Zabaleta, Pere Cardona Portela, Rocío Vera, Lucia Lebrato-Hernández, Juan F. Arenillas, Soledad Pérez-Sánchez, Ana Domínguez-Mayoral, Joan Martí Fàbregas, Gerard Mauri, Joan Montaner, Jose Luis Sánchez-Quesada & Mar Hernández-Guillamon. (2023) Association of candidate genetic variants and circulating levels of ApoE/ApoJ with common neuroimaging features of cerebral amyloid angiopathy. Frontiers in Aging Neuroscience 15.
Crossref
Mahendran Sekar, Pei Teng Lum, Srinivasa Reddy Bonam & Siew Hua Gan. 2023. Honey. Honey 302 313 .
Manisha Vohra, Mohammad Amir, Amit Sharma & Sheetu Wadhwa. (2023) Formulation strategies for nose-to-brain drug delivery in Alzheimer's disease. Health Sciences Review 6, pages 100075.
Crossref
Joan S. Baizer & Sandra F. Witelson. (2023) Comparative analysis of four nuclei in the human brainstem: Individual differences, left-right asymmetry, species differences. Frontiers in Neuroanatomy 17.
Crossref
Angelika Chachaj, Kazimierz Gąsiorowski, Andrzej Szuba, Adrian Sieradzki & Jerzy Leszek. (2023) The Lymphatic System In The Brain Clearance Mechanisms - New Therapeutic Perspectives For Alzheimer's Disease. Current Neuropharmacology 21:2, pages 380-391.
Crossref
Softya Sebastian, Swarup Roy & Jugal Kalita. (2023) A generic parallel framework for inferring large-scale gene regulatory networks from expression profiles: application to Alzheimer’s disease network. Briefings in Bioinformatics 24:1.
Crossref
James Michael Brimson, Mani Iyer Prasanth, Discon Sheeja Malar, Kanika Verma, Waluga Plaingam & Tewin Tencomnao. (2022) Bacopa monnieri protects neuronal cell line and Caenorhabditis elegans models of Alzheimer’s disease through sigma-1 receptor antagonist sensitive and antioxidant pathways. Nutrition and Healthy Aging 7:3-4, pages 173-196.
Crossref
Peter Bor‐Chian Lin, Andy Po‐Yi Tsai, Disha Soni, Audrey Lee‐Gosselin, Miguel Moutinho, Shweta S. Puntambekar, Gary E. Landreth, Bruce T. Lamb & Adrian L. Oblak. (2022) INPP5D deficiency attenuates amyloid pathology in a mouse model of Alzheimer's disease . Alzheimer's & Dementia.
Crossref
Eileen C. Limanjaya, Dionysius Subali & Yanti Yanti. (2022) The anti-Alzheimer compounds from tempeh oil in LPS-induced neuronal Schwann cells. Journal of Ethnic Foods 9:1.
Crossref
Nastaran Karimi, Feyza Bayram Çatak, Ebru Arslan, Amene Saghazadeh & Nima Rezaei. (2022) Tau immunotherapy in Alzheimer’s disease and progressive supranuclear palsy. International Immunopharmacology 113, pages 109445.
Crossref
Simran Chauhan, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Sumeet Gupta, Mohammed Albratty, Asim Najmi, Abdulkarim M. Meraya & Hassan A. Alhazmi. (2022) Understanding the Intricate Role of Exosomes in Pathogenesis of Alzheimer’s Disease. Neurotoxicity Research 40:6, pages 1758-1773.
Crossref
Ruth E. Mark & Yvonne Brehmer. (2022) Preclinical Alzheimer’s dementia: a useful concept or another dead end?. European Journal of Ageing 19:4, pages 997-1004.
Crossref
Marta Sochocka, Michał Ochnik, Maciej Sobczyński, Beata Orzechowska & Jerzy Leszek. (2022) Sex Differences in Innate Immune Response of Peripheral Blood Leukocytes of Alzheimer’s Disease Patients. Archivum Immunologiae et Therapiae Experimentalis 70:1.
Crossref
Katerina Pierouli, Eleni Papakonstantinou, Louis Papageorgiou, Io Diakou, Thanasis Mitsis, Konstantina Dragoumani, Demetrios Spandidos, Flora Bacopoulou, George Chrousos, George Goulielmos, Elias Eliopoulos & Dimitrios Vlachakis. (2022) Role of non‑coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review). International Journal of Molecular Medicine 51:1.
Crossref
Jeffrey Cummings, Andrew Ortiz, Janelle Castellino & Jefferson Kinney. (2022) Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease. European Journal of Neuroscience 56:9, pages 5727-5757.
Crossref
Florinda Ferreri, Francesca Miraglia, Fabrizio Vecchio, Nicoletta Manzo, Maria Cotelli, Elda Judica & Paolo Maria Rossini. (2022) Electroencephalographic hallmarks of Alzheimer’s disease. International Journal of Psychophysiology 181, pages 85-94.
Crossref
Megan Sullivan, Hong-Wen Deng & Jonathan Greenbaum. (2022) Identification of genetic loci shared between Alzheimer’s disease and hypertension. Molecular Genetics and Genomics 297:6, pages 1661-1670.
Crossref
Tirthankar Sen & Rajkumar P. Thummer. (2022) CRISPR and iPSCs: Recent Developments and Future Perspectives in Neurodegenerative Disease Modelling, Research, and Therapeutics. Neurotoxicity Research 40:5, pages 1597-1623.
Crossref
Ibtisam Mumtaz, Mir Owais Ayaz, Mohamad Sultan Khan, Umar Manzoor, Mohd Azhardin Ganayee, Aadil Qadir Bhat, Ghulam Hassan Dar, Badrah S. Alghamdi, Anwar M. Hashem, Mohd Jamal Dar, Gulam Md. Ashraf & Tariq Maqbool. (2022) Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer’s disease. Frontiers in Aging Neuroscience 14.
Crossref
Venzil Lavie Dsouza, Apoorva Bettagere Shivakumar, Nikshitha Kulal, Gireesh Gangadharan, Dileep Kumar & Shama Prasada Kabekkodu. (2022) Phytochemical based Modulation of Endoplasmic Reticulum Stress in Alzheimer's Disease. Current Topics in Medicinal Chemistry 22:22, pages 1880-1896.
Crossref
Miren Altuna, Rosa Larumbe, María Victoria Zelaya, Sira Moreno, Virginia García-Solaesa, Maite Mendioroz, María Antonia Ramos & María Elena Erro. (2022) Progressive cognitive impairment and familial spastic paraparesis due to PRESENILIN 1 mutation: anatomoclinical characterization. Journal of Neurology 269:9, pages 4853-4862.
Crossref
Patricia Sinclair & Nadine Kabbani. (2022) Nicotinic receptor components of amyloid beta 42 proteome regulation in human neural cells. PLOS ONE 17:8, pages e0270479.
Crossref
Gabriela Dumitrita Stanciu, Daniela Carmen Ababei, Razvan Nicolae Rusu, Veronica Bild & Bogdan-Ionel Tamba. (2022) Exploring the Involvement of the Amyloid Precursor Protein A673T Mutation against Amyloid Pathology and Alzheimer’s Disease in Relation to Therapeutic Editing Tools. Pharmaceutics 14:6, pages 1270.
Crossref
Sercan Kenanoglu, Nefise Kandemir, Hilal Akalin, Nuriye Gokce, Mehmet F. Gol, Murat Gultekin, Emel Koseoglu, Meral Mirza & Munis Dundar. (2022) Evaluation of Utilizing the Distinct Genes as Predictive Biomarkers in Late-Onset Alzheimer's Disease. Global Medical Genetics 09:02, pages 110-117.
Crossref
Ghazal Mirabnahrazam, Da Ma, Sieun Lee, Karteek Popuri, Hyunwoo Lee, Jiguo Cao, Lei Wang, James E. Galvin & Mirza Faisal Beg. (2022) Machine Learning Based Multimodal Neuroimaging Genomics Dementia Score for Predicting Future Conversion to Alzheimer’s Disease. Journal of Alzheimer's Disease 87:3, pages 1345-1365.
Crossref
Lijun Wang, Yang Jiao, Aonan Zhao, Xiaomeng Xu, Guanyu Ye, Yichi Zhang, Ying Wang, Yulei Deng, Wei Xu & Jun Liu. (2022) Analysis of Genetic Association Between ABCA7 Polymorphism and Alzheimer’s Disease Risk in the Southern Chinese Population. Frontiers in Aging Neuroscience 14.
Crossref
María D. Navarro-Hortal, Jose M. Romero-Márquez, Safa Osta, Victoria Jiménez-Trigo, Pedro Muñoz-Ollero & Alfonso Varela-López. (2022) Natural Bioactive Products and Alzheimer’s Disease Pathology: Lessons from Caenorhabditis elegans Transgenic Models. Diseases 10:2, pages 28.
Crossref
Xiaoyan Du, Lianzhong Luo, Qingyu Huang & Jie Zhang. (2022) Cortex metabolome and proteome analysis reveals chronic arsenic exposure via drinking water induces developmental neurotoxicity through hnRNP L mediated mitochondrial dysfunction in male rats. Science of The Total Environment 820, pages 153325.
Crossref
Meigang Ma, Yuhan Liao, Xiaohua Huang, Chun Zou, Liechun Chen, Lucong Liang, Youshi Meng, Yuan Wu & Donghua Zou. (2022) Identification of Alzheimer’s Disease Molecular Subtypes Based on Parallel Large-Scale Sequencing. Frontiers in Aging Neuroscience 14.
Crossref
Danielle Marie Reid, Robert C. Barber, Roland J. ThorpeJr.Jr., Jie Sun, Zhengyang Zhou & Nicole R. Phillips. (2022) Mitochondrial DNA oxidative mutations are elevated in Mexican American women potentially implicating Alzheimer’s disease. npj Aging 8:1.
Crossref
Manish Kumar & Nitin Bansal. (2022) A Revisit to Etiopathogenesis and Therapeutic Strategies in Alzheimer’s Disease. Current Drug Targets 23:5, pages 486-512.
Crossref
Maria Laura Ontario, Rosalba Siracusa, Sergio Modafferi, Maria Scuto, Sebastiano Sciuto, Valentina Greco, Maria Paola Bertuccio, Angela Trovato Salinaro, Roberto Crea, Edward J. Calabrese, Rosanna Di Paola & Vittorio Calabrese. (2022) Potential prevention and treatment of neurodegenerative disorders by olive polyphenols and hidrox. Mechanisms of Ageing and Development 203, pages 111637.
Crossref
Himanshu Narayan Singh, Vishnu Swarup, Navneet Kumar Dubey, Niraj Kumar Jha, Anjani Kumar Singh, Wen-Cheng Lo & Sanjay Kumar. (2022) Differential Transcriptome Profiling Unveils Novel Deregulated Gene Signatures Involved in Pathogenesis of Alzheimer’s Disease. Biomedicines 10:3, pages 611.
Crossref
Beatriz Correia, Joana Fernandes, Maria João Botica, Carla Ferreira & Alexandre Quintas. (2022) Novel Psychoactive Substances: The Razor’s Edge between Therapeutical Potential and Psychoactive Recreational Misuse. Medicines 9:3, pages 19.
Crossref
John O. Ogbodo, Chinazom P. Agbo, Ugochi O. Njoku, Martins O. Ogugofor, Simeon I. Egba, Stella A. Ihim, Adaeze C. Echezona, Kenneth C. Brendan, Aman B. Upaganlawar & Chandrashekhar D. Upasani. (2022) Alzheimer’s Disease: Pathogenesis and Therapeutic Interventions. Current Aging Science 15:1, pages 2-25.
Crossref
Liling Dong, Chenhui Mao, Caiyan Liu, Jie Li, Xinying Huang, Jie Wang, Dan Lei, Shanshan Chu, Longze Sha, Qi Xu, Bin Peng, Liying Cui & Jing Gao. (2022) Association Between Common Variants of APOE, ABCA7, A2M, BACE1, and Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease: Data from the PUMCH Dementia Cohort. Journal of Alzheimer's Disease 85:4, pages 1511-1518.
Crossref
Serena Silvestro, Andrea Valeri & Emanuela Mazzon. (2022) Aducanumab and Its Effects on Tau Pathology: Is This the Turning Point of Amyloid Hypothesis?. International Journal of Molecular Sciences 23:4, pages 2011.
Crossref
Fatemah Sakr, Martin Dyrba, Anja Bräuer & Stefan Teipel. (2022) Association of Lipidomics Signatures in Blood with Clinical Progression in Preclinical and Prodromal Alzheimer’s Disease. Journal of Alzheimer's Disease 85:3, pages 1115-1127.
Crossref
Md Afroz Ahmad, Ozaifa Kareem, Mohammad Khushtar, Md Akbar, Md Rafiul Haque, Ashif Iqubal, Md Faheem Haider, Faheem Hyder Pottoo, Fatima S. Abdulla, Mahia B. Al-Haidar & Noora Alhajri. (2022) Neuroinflammation: A Potential Risk for Dementia. International Journal of Molecular Sciences 23:2, pages 616.
Crossref
Xiaoyu Zhang, Meijaun Zou, Yuwei Wu, Danli Jiang, Ting Wu, Yihan Zhao, Di Wu, Jing Cui & Gang Li. (2022) Regulation of the Late Onset alzheimer’s Disease Associated HLA-DQA1/DRB1 Expression . American Journal of Alzheimer's Disease & Other Dementias® 37, pages 153331752210850.
Crossref
Remi Daviet, Gideon Nave & Jerry Wind. (2021) Genetic Data: Potential Uses and Misuses in Marketing. Journal of Marketing 86:1, pages 7-26.
Crossref
Victoria Fleming, Christy L. Hom, Isabel C.H. Clare, Shemaya L. Hurd-Thomas, Sharon Krinsky-McHale, Benjamin Handen & Sigan L. Hartley. 2022. Contemporary Issues in Evaluating Treatment Outcomes in Neurodevelopmental Disorders. Contemporary Issues in Evaluating Treatment Outcomes in Neurodevelopmental Disorders 227 263 .
Jennifer L. Johnson & Lance A. Johnson. 2022. Encyclopedia of Behavioral Neuroscience, 2nd edition. Encyclopedia of Behavioral Neuroscience, 2nd edition 372 382 .
Romain Chassefeyre, Tai Chaiamarit, Adriaan Verhelle, Sammy Weiser NovakLeonardo R. Andrade, André D. G. Leitão, Uri Manor & Sandra E. Encalada. (2021) Endosomal sorting drives the formation of axonal prion protein endoggresomes. Science Advances 7:52.
Crossref
Aleksander Turk, Tanja Kunej & Borut Peterlin. (2021) MicroRNA-Target Interaction Regulatory Network in Alzheimer’s Disease. Journal of Personalized Medicine 11:12, pages 1275.
Crossref
Vincent Pons, Pascal Lévesque, Marie-Michèle Plante & Serge Rivest. (2021) Conditional genetic deletion of CSF1 receptor in microglia ameliorates the physiopathology of Alzheimer’s disease. Alzheimer's Research & Therapy 13:1.
Crossref
Biswajit Padhy & Debasmita Pankaj Alone. (2021) Is pseudoexfoliation glaucoma a neurodegenerative disorder?. Journal of Biosciences 46:4.
Crossref
Stefania Kalampokini, Despoina Georgouli, Eleni Patrikiou, Antonios Provatas, Varvara Valotassiou, Panagiotis Georgoulias, Cleanthe Spanaki, Georgios M. Hadjigeorgiou & Georgia Xiromerisiou. (2021) The Greek Variant in APP Gene: The Phenotypic Spectrum of APP Mutations. International Journal of Molecular Sciences 22:22, pages 12355.
Crossref
Richard Fairless, Hilmar Bading & Ricarda Diem. (2021) Pathophysiological Ionotropic Glutamate Signalling in Neuroinflammatory Disease as a Therapeutic Target. Frontiers in Neuroscience 15.
Crossref
Nermeen Z. Abuelezz, Fayza Eid Nasr, Mohammad Ahmed AbdulKader, Ahmad R. Bassiouny & Amira Zaky. (2021) MicroRNAs as Potential Orchestrators of Alzheimer's Disease-Related Pathologies: Insights on Current Status and Future Possibilities. Frontiers in Aging Neuroscience 13.
Crossref
Martina Blank & Carsten Hopf. (2020) Spatially resolved mass spectrometry analysis of amyloid plaque‐associated lipids. Journal of Neurochemistry 159:2, pages 330-342.
Crossref
SWETHA G.ANJALI RAJ, SANIYA TABASSUM & DOUGLAS ZORINMAWIA CHHAKCHHUAK. (2021) OXIDATIVE STRESS IN ALZHEIMER’S DISEASE–EVALUATING THE AMYLOID BETA HYPOTHESIS. International Journal of Current Pharmaceutical Research, pages 32-38.
Crossref
Rajmohamed Mohamed Asik, Natarajan Suganthy, Mohamed Asik Aarifa, Arvind Kumar, Krisztián Szigeti, Domokos Mathe, Balázs Gulyás, Govindaraju Archunan & Parasuraman Padmanabhan. (2021) Alzheimer’s Disease: A Molecular View of β-Amyloid Induced Morbific Events. Biomedicines 9:9, pages 1126.
Crossref
Nofar Stolero & Dan Frenkel. (2021) The dialog between neurons and microglia in Alzheimer's disease: The neurotransmitters view. Journal of Neurochemistry 158:6, pages 1412-1424.
Crossref
Sigal Levy, Nili Guttmann-Beck & Dorit Shweiki. (2021) Clustering Alzheimer’s Disease Gene Expression Dataset Reveals Underlying Sexually Dimorphic and Disease Status Profiles. Journal of Alzheimer's Disease Reports 5:1, pages 541-547.
Crossref
Dimitrios Vlachakis, Eleni Papakonstantinou, Ram Sagar, Flora Bacopoulou, Themis Exarchos, Panos Kourouthanassis, Vasileios Karyotis, Panayiotis Vlamos, Constantine Lyketsos, Dimitrios Avramopoulos & Vasiliki Mahairaki. (2021) Improving the Utility of Polygenic Risk Scores as a Biomarker for Alzheimer’s Disease. Cells 10:7, pages 1627.
Crossref
Daniela Puzzo & Fiorenzo Conti. (2021) Conceptual and Methodological Pitfalls in Experimental Studies: An Overview, and the Case of Alzheimer’s Disease. Frontiers in Molecular Neuroscience 14.
Crossref
Md. Abdul Barek, Md. Abdul Aziz, Sarah Jafrin & Mohammad Safiqul Islam. (2021) Association of GOLPH2 gene polymorphisms (rs10868366 and rs7019241) with the risk of Alzheimer's disease: Evidence from a meta-analysis. Meta Gene 28, pages 100868.
Crossref
Matthew G. Pontifex, Anneloes Martinsen, Rasha Noureldin M. Saleh, Glenn Harden, Noemi Tejera, Michael Müller, Chris Fox, David Vauzour & Anne‐Marie Minihane. (2021) APOE4 genotype exacerbates the impact of menopause on cognition and synaptic plasticity in APOE‐TR mice. The FASEB Journal 35:5.
Crossref
Hissa F. Al-Thani, Muneera N. Ahmad, Salma Younes & Hatem Zayed. (2021) Genetic Variants Associated With Alzheimer Disease in the 22 Arab Countries. Alzheimer Disease & Associated Disorders 35:2, pages 178-186.
Crossref
Punam Rawal & Liqin Zhao. (2021) Sialometabolism in Brain Health and Alzheimer’s Disease. Frontiers in Neuroscience 15.
Crossref
Stéphane L. Benoit & Robert J. Maier. (2021) The nickel-chelator dimethylglyoxime inhibits human amyloid beta peptide in vitro aggregation. Scientific Reports 11:1.
Crossref
Susana López-Ortiz, Jose Pinto-Fraga, Pedro L. Valenzuela, Juan Martín-Hernández, María M. Seisdedos, Oscar García-López, Nicola Toschi, Francesca Di Giuliano, Francesco Garaci, Nicola Biagio Mercuri, Robert Nisticò, Enzo Emanuele, Simone Lista, Alejandro Lucia & Alejandro Santos-Lozano. (2021) Physical Exercise and Alzheimer’s Disease: Effects on Pathophysiological Molecular Pathways of the Disease. International Journal of Molecular Sciences 22:6, pages 2897.
Crossref
Pragya Prasanna & Arun Upadhyay. (2021) Flavonoid-Based Nanomedicines in Alzheimer’s Disease Therapeutics: Promises Made, a Long Way To Go. ACS Pharmacology & Translational Science 4:1, pages 74-95.
Crossref
Min Li, Rongxin Geng, Chen Li, Fantao Meng, Hongwei Zhao, Jing Liu, Juanjuan Dai & Xuezhen Wang. (2021) Dysregulated gene-associated biomarkers for Alzheimer’s disease and aging. Translational Neuroscience 12:1, pages 83-95.
Crossref
Vladimir J. Balcar, Tomáš Zeman, Vladimír Janout, Jana Janoutová, Jan Lochman & Omar Šerý. (2020) Single Nucleotide Polymorphism rs11136000 of CLU Gene (Clusterin, ApoJ) and the Risk of Late-Onset Alzheimer’s Disease in a Central European Population. Neurochemical Research 46:2, pages 411-422.
Crossref
Periyanaina Kesika, Natarajan Suganthy, Bhagavathi Sundaram Sivamaruthi & Chaiyavat Chaiyasut. (2021) Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease. Life Sciences 264, pages 118627.
Crossref
Dharmendra Kumar Khatri, Amey Kadbhane, Monica Patel, Shweta Nene, Srividya Atmakuri, Saurabh Srivastava & Shashi Bala Singh. (2021) Gauging the role and impact of drug interactions and repurposing in neurodegenerative disorders. Current Research in Pharmacology and Drug Discovery 2, pages 100022.
Crossref
Stuart M. Raleigh & Tom Cullen. 2021. Epigenetics of Exercise and Sports. Epigenetics of Exercise and Sports 201 216 .
Julie Wendt, Colleen Considine & Mikhail KoganJulie Wendt, Colleen Considine & Mikhail Kogan. 2021. Integrative Geriatric Nutrition. Integrative Geriatric Nutrition 193 207 .
Julie Hoogmartens, Rita Cacace & Christine Van Broeckhoven. (2021) Insight into the genetic etiology of Alzheimer's disease: A comprehensive review of the role of rare variants. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 13:1.
Crossref
Vladimir Khavinson, Natalia Linkova, Ekaterina Kozhevnikova & Svetlana Trofimova. (2020) EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer’s Disease. Molecules 26:1, pages 159.
Crossref
Natasha Vassileff, Lesley Cheng & Andrew F. Hill. (2020) Extracellular vesicles – propagators of neuropathology and sources of potential biomarkers and therapeutics for neurodegenerative diseases. Journal of Cell Science 133:23.
Crossref
Xavier Taylor, Pablo Cisternas, Yanwen You, Yingjian You, Shunian Xiang, Yamil Marambio, Jie Zhang, Ruben Vidal & Cristian A. Lasagna-Reeves. (2020) A1 reactive astrocytes and a loss of TREM2 are associated with an early stage of pathology in a mouse model of cerebral amyloid angiopathy. Journal of Neuroinflammation 17:1.
Crossref
Mikko Kärkkäinen, Mithilesh Prakash, Marzieh Zare, Jussi Tohka & for the Alzheimer's Disease Neuroimaging Initiative. (2020) Structural Brain Imaging Phenotypes of Mild Cognitive Impairment (MCI) and Alzheimer’s Disease (AD) Found by Hierarchical Clustering. International Journal of Alzheimer's Disease 2020, pages 1-13.
Crossref
Rashmi Gamage, Ingrid Wagnon, Ilaria Rossetti, Ryan Childs, Garry Niedermayer, Rose Chesworth & Erika Gyengesi. (2020) Cholinergic Modulation of Glial Function During Aging and Chronic Neuroinflammation. Frontiers in Cellular Neuroscience 14.
Crossref
Chinthalapally V. Rao, Mudassir Farooqui, Avanish Madhavaram, Yuting Zhang, Adam S. Asch & Hiroshi Y. Yamada. (2020) GSK3‐ARC/Arg3.1 and GSK3‐Wnt signaling axes trigger amyloid‐β accumulation and neuroinflammation in middle‐aged Shugoshin 1 mice. Aging Cell 19:10.
Crossref
Sergio Claudio Saccà, Filippo Paluan, Stefano Gandolfi, Gianluca Manni, Carlo Alberto Cutolo & Alberto Izzotti. (2020) Common aspects between glaucoma and brain neurodegeneration. Mutation Research/Reviews in Mutation Research 786, pages 108323.
Crossref
Qi Qin, Yunsi Yin, Yan Wang, Yuanyuan Lu, Yi Tang & Jianping Jia. (2020) Gene mutations associated with early onset familial Alzheimer’s disease in China: An overview and current status. Molecular Genetics & Genomic Medicine 8:10.
Crossref
Alexei Kurakin & Dale E. Bredesen. (2020) Alzheimer’s disease as a systems network disorder: chronic stress/dyshomeostasis, innate immunity, and genetics. Aging 12:18, pages 17815-17844.
Crossref
Chiara Argentati, Ilaria Tortorella, Martina Bazzucchi, Carla Emiliani, Francesco Morena & Sabata Martino. (2020) The Other Side of Alzheimer’s Disease: Influence of Metabolic Disorder Features for Novel Diagnostic Biomarkers. Journal of Personalized Medicine 10:3, pages 115.
Crossref
Nicolai M. Stoye, Malena Santos Guilherme & Kristina Endres. (2020) Alzheimer's disease in the gut—Major changes in the gut of 5xFAD model mice with ApoA1 as potential key player. The FASEB Journal 34:9, pages 11883-11899.
Crossref
Abram Giller, Mariana Andrawus, Danielle Gutman & Gil Atzmon. (2020) Pregnancy as a model for aging. Ageing Research Reviews 62, pages 101093.
Crossref
Jessica S. Sadick, Lorin A. Crawford, Harry C. CramerIIIIII, Christian Franck, Shane A. Liddelow & Eric M. Darling. (2020) Generating Cell Type-Specific Protein Signatures from Non-symptomatic and Diseased Tissues. Annals of Biomedical Engineering 48:8, pages 2218-2232.
Crossref
Sphelele Sosibo, Daniel Gyamfi Amoako, Anou Moise Somboro, Darren Delai Sun, Jane Catherine Ngila & Hezekiel Kumalo. (2020) Understanding the Binding Mechanism of Antagonist (AZD3293) Against BACE-1: Molecular Insights into Alzheimer’s Drug Discovery. Letters in Drug Design & Discovery 17:7, pages 850-857.
Crossref
Gargi Pal, Lia Di, Akintunde Orunmuyi, E Oluwabunmi Olapade-Olaopa, Weigang Qiu & Olorunseun O Ogunwobi. (2020) Population Differentiation at the PVT1 Gene Locus: Implications for Prostate Cancer. G3 Genes|Genomes|Genetics 10:7, pages 2257-2264.
Crossref
Shashikala Bhute, Deepaneeta Sarmah, Aishika Datta, Pallavi Rane, Amit Shard, Avirag Goswami, Anupom Borah, Kiran Kalia, Kunjan R. Dave & Pallab Bhattacharya. (2020) Molecular Pathogenesis and Interventional Strategies for Alzheimer’s Disease: Promises and Pitfalls. ACS Pharmacology & Translational Science 3:3, pages 472-488.
Crossref
P.M. Rossini, R. Di Iorio, F. Vecchio, M. Anfossi, C. Babiloni, M. Bozzali, A.C. Bruni, S.F. Cappa, J. Escudero, F.J. Fraga, P. Giannakopoulos, B. Guntekin, G. Logroscino, C. Marra, F. Miraglia, F. Panza, F. Tecchio, A. Pascual-Leone & B. Dubois. (2020) Early diagnosis of Alzheimer’s disease: the role of biomarkers including advanced EEG signal analysis. Report from the IFCN-sponsored panel of experts. Clinical Neurophysiology 131:6, pages 1287-1310.
Crossref
Katalin E. Sos, Márton I. Mayer, Virág T. Takács, Abel Major, Zsuzsanna Bardóczi, Barnabas M. Beres, Tamás Szeles, Takashi Saito, Takaomi C. Saido, István Mody, Tamás F. Freund & Gábor Nyiri. (2020) Amyloid β induces interneuron-specific changes in the hippocampus of APPNL-F mice. PLOS ONE 15:5, pages e0233700.
Crossref
Juan Luis Fernández-Martínez, Óscar Álvarez-Machancoses, Enrique J. deAndrés-Galiana, Guillermina Bea & Andrzej Kloczkowski. (2020) Robust Sampling of Defective Pathways in Alzheimer’s Disease. Implications in Drug Repositioning. International Journal of Molecular Sciences 21:10, pages 3594.
Crossref
Michal Prendecki, Marta Kowalska, Ewa Toton & Wojciech Kozubski. (2020) Genetic Editing and Pharmacogenetics in Current And Future Therapy Of Neurocognitive Disorders. Current Alzheimer Research 17:3, pages 238-258.
Crossref
Valerio Caputo, Andrea Termine, Claudia Strafella, Emiliano Giardina & Raffaella Cascella. (2020) Shared (epi)genomic background connecting neurodegenerative diseases and type 2 diabetes. World Journal of Diabetes 11:5, pages 155-164.
Crossref
Eva Bagyinszky, Vo Van Giau & SeongSoo A. An. (2020) Transcriptomics in Alzheimer’s Disease: Aspects and Challenges. International Journal of Molecular Sciences 21:10, pages 3517.
Crossref
Anna Slanzi, Giulia Iannoto, Barbara Rossi, Elena Zenaro & Gabriela Constantin. (2020) In vitro Models of Neurodegenerative Diseases. Frontiers in Cell and Developmental Biology 8.
Crossref
Pan Xiaodong, Yang Murong, Xiang Jingjing, Pan Qi, Yang Menghao, Xia Jing, Cui Lang, Luo Ruijie, Lou Qinlin, Zhou Chen, He Yiran & Zhu Kuichun. (2020) Identification of Novel Gene variants in Patients with Alzheimer’s Disease by Whole Exome Sequencing. Annals of Alzheimer's and Dementia Care 4:1, pages 001-004.
Crossref
M. Gunata, H. Parlakpinar & H.A. Acet. (2020) Melatonin: A review of its potential functions and effects on neurological diseases. Revue Neurologique 176:3, pages 148-165.
Crossref
Yu-Chia Kao, Pei-Chuan Ho, Yuan-Kun Tu, I-Ming Jou & Kuen-Jer Tsai. (2020) Lipids and Alzheimer’s Disease. International Journal of Molecular Sciences 21:4, pages 1505.
Crossref
Jacob S. Friedberg, Nurgul Aytan, Jonathan D. Cherry, Weiming Xia, Oliver J. Standring, Victor E. Alvarez, Raymond Nicks, Sarah Svirsky, Gaoyuan Meng, Gyungah Jun, Hoon Ryu, Rhoda Au & Thor D. Stein. (2020) Associations between brain inflammatory profiles and human neuropathology are altered based on apolipoprotein E ε4 genotype. Scientific Reports 10:1.
Crossref
Francesc X. Guix. (2019) The interplay between aging‐associated loss of protein homeostasis and extracellular vesicles in neurodegeneration. Journal of Neuroscience Research 98:2, pages 262-283.
Crossref
Liyuan Fan, Chengyuan Mao, Xinchao Hu, Shuo Zhang, Zhihua Yang, Zhengwei Hu, Huifang Sun, Yu Fan, Yali Dong, Jing Yang, Changhe Shi & Yuming Xu. (2020) New Insights Into the Pathogenesis of Alzheimer's Disease. Frontiers in Neurology 10.
Crossref
Junpei Sugioka, Shota Suzumura, Yasuhiro Kawahara, Aiko Osawa, Natsumi Maeda, Misato Ito, Taishi Nagahama, Katsumi Kuno, Kenta Shiramoto, Shiori Kizuka, Tomohiko Mizuguchi, Yuko Sano, Akihiko Kandori & Izumi Kondo. (2020) Assessment of finger movement characteristics in dementia patients using a magnetic sensing finger-tap device. Japanese Journal of Comprehensive Rehabilitation Science 11:0, pages 91-97.
Crossref
Marcella Reale, Isabella Gonzales-Portillo & Cesar V. Borlongan. (2020) Saliva, an easily accessible fluid as diagnostic tool and potent stem cell source for Alzheimer’s Disease: Present and future applications. Brain Research 1727, pages 146535.
Crossref
Raj V. Kavitha, J.R. Kumar, Chukwuebuka Egbuna & Jonathan C. Ifemeje. 2020. Phytochemicals as Lead Compounds for New Drug Discovery. Phytochemicals as Lead Compounds for New Drug Discovery 161 178 .
Francesca Fernandez & Jessica L. Andrews. 2020. Diagnosis and Management in Dementia. Diagnosis and Management in Dementia 127 146 .
Francesca L. Guest, Hassan Rahmoune & Paul C. Guest. 2020. Reviews on New Drug Targets in Age-Related Disorders. Reviews on New Drug Targets in Age-Related Disorders 175 191 .
Pablo Cisternas, Xavier Taylor & Cristian A. Lasagna-Reeves. (2019) The Amyloid-Tau-Neuroinflammation Axis in the Context of Cerebral Amyloid Angiopathy. International Journal of Molecular Sciences 20:24, pages 6319.
Crossref
Kaloyan R. Stoychev, Maya Stoimenova-Popova, Petranka Chumpalova, Lilia Ilieva, Mohamed Swamad & Zornitsa Kamburova-Martinova. (2019) A Clinical Case of Patient Carrying Rare Pathological PSEN1 Gene Mutation (L424V) Demonstrates the Phenotypic Heterogenity of Early Onset Familial AD. Frontiers in Psychiatry 10.
Crossref
Marcos Vinícius Ferreira Silva, Cristina de Mello Gomide Loures, Luan Carlos Vieira Alves, Leonardo Cruz de Souza, Karina Braga Gomes Borges & Maria das Graças Carvalho. (2019) Alzheimer’s disease: risk factors and potentially protective measures. Journal of Biomedical Science 26:1.
Crossref
Rasmus Bjerregaard MikkelsenHenriette Reventlow S. FrederiksenMickey GjerrisBjørn HolstPoul HyttelYonglun LuoKristine FreudePeter Sandøe. (2019) Genetic Protection Modifications: Moving Beyond the Binary Distinction Between Therapy and Enhancement for Human Genome Editing. The CRISPR Journal 2:6, pages 362-369.
Crossref
Dong Kyu Kim, Dohyun Han, Joonho Park, Hyunjung Choi, Jong-Chan Park, Moon-Yong Cha, Jongmin Woo, Min Soo Byun, Dong Young Lee, Youngsoo Kim & Inhee Mook-Jung. (2019) Deep proteome profiling of the hippocampus in the 5XFAD mouse model reveals biological process alterations and a novel biomarker of Alzheimer’s disease. Experimental & Molecular Medicine 51:11, pages 1-17.
Crossref
Renuka Prasad G & Eek-hoon Jho. (2019) A concise review of human brain methylome during aging and neurodegenerative diseases. BMB Reports 52:10, pages 577-588.
Crossref
Dylan Kwart, Andrew Gregg, Claudia Scheckel, Elisabeth A. Murphy, Dominik Paquet, Michael Duffield, John Fak, Olav Olsen, Robert B. Darnell & Marc Tessier-Lavigne. (2019) A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ. Neuron 104:2, pages 256-270.e5.
Crossref
Han Jieh Tey & Chong Han Ng. (2019) Computational analysis of functional SNPs in Alzheimer’s disease-associated endocytosis genes. PeerJ 7, pages e7667.
Crossref
Fahad Ali & Yasir Hasan Siddique. (2019) Bioavailability and Pharmaco-therapeutic Potential of Luteolin in Overcoming Alzheimer’s Disease. CNS & Neurological Disorders - Drug Targets 18:5, pages 352-365.
Crossref
Arvey Camilo Villalba, Jenny García, Claudia Ramos, Amanda Rosario Cuastumal, David Aguillón, Daniel Camilo Aguirre-Acevedo, Lucia Madrigal & Francisco Lopera. (2019) Mental Disorders in Young Adults from Families with the Presenilin-1 Gene Mutation E280A in the Preclinical Stage of Alzheimer’s Disease. Journal of Alzheimer's Disease Reports 3:1, pages 241-250.
Crossref
Silvestro, Bramanti & Mazzon. (2019) Role of miRNAs in Alzheimer's Disease and Possible Fields of Application. International Journal of Molecular Sciences 20:16, pages 3979.
Crossref
Arvey Camilo Villalba, Jenny García, Claudia Ramos, Amanda Rosario Cuastumal, David Aguillón, Daniel Camilo Aguirre-Acevedo, Lucia Madrigal & Francisco Lopera. (2019) Mental Disorders in Young Adults from Families with the Presenilin-1 Gene Mutation E280A in the Preclinical Stage of Alzheimer’s Disease. Journal of Alzheimer's Disease, pages 1-10.
Crossref
José Ángel Martínez-Menárguez, Mónica Tomás, Narcisa Martínez-Martínez & Emma Martínez-Alonso. (2019) Golgi Fragmentation in Neurodegenerative Diseases: Is There a Common Cause?. Cells 8:7, pages 748.
Crossref
Nobutaka Masuoka, Chitose Yoshimine, Marie Hori, Mieko Tanaka, Takashi Asada, Keiichi Abe & Tatsuhiro Hisatsune. (2019) Effects of Anserine/Carnosine Supplementation on Mild Cognitive Impairment with APOE4. Nutrients 11:7, pages 1626.
Crossref
Rafael Franco, Gemma Navarro & Eva Martínez-Pinilla. (2019) Lessons on Differential Neuronal-Death-Vulnerability from Familial Cases of Parkinson’s and Alzheimer’s Diseases. International Journal of Molecular Sciences 20:13, pages 3297.
Crossref
Manuel A. Castro, Arina Hadziselimovic & Charles R. Sanders. (2019) The vexing complexity of the amyloidogenic pathway. Protein Science 28:7, pages 1177-1193.
Crossref
Stephanie J. Fuller, Hamid R. Sohrabi, Kathryn G. Goozee, Anoop Sankaranarayanan & Ralph N. Martins. 2019. Neurodegeneration and Alzheimer's Disease. Neurodegeneration and Alzheimer's Disease 9 42 .
Tenielle Porter, Aleksandra K. Gozt, Francis L. Mastaglia & Simon M. Laws. 2019. Neurodegeneration and Alzheimer's Disease. Neurodegeneration and Alzheimer's Disease 443 498 .
Neha Sinha, Zachariah M. Reagh, Nicholas J. Tustison, Chelsie N. Berg, Ashlee Shaw, Catherine E. Myers, Diane Hill, Michael A. Yassa & Mark A. Gluck. (2018) ABCA7 risk variant in healthy older African Americans is associated with a functionally isolated entorhinal cortex mediating deficient generalization of prior discrimination training. Hippocampus 29:6, pages 527-538.
Crossref
Michelle Esposito & Goldie Libby Sherr. (2019) Epigenetic Modifications in Alzheimer’s Neuropathology and Therapeutics. Frontiers in Neuroscience 13.
Crossref
Erica C. Dresselhaus & Mollie K. Meffert. (2019) Cellular Specificity of NF-κB Function in the Nervous System. Frontiers in Immunology 10.
Crossref
Pei‐Chen Hsieh, Chun‐Chieh Wang, Chia‐Lung Tsai, Yuan‐Ming Yeh, Yun Shien Lee & Yih‐Ru Wu. (2019) POLG R964C and GBA L444P mutations in familial Parkinson's disease: Case report and literature review . Brain and Behavior 9:5, pages e01281.
Crossref
Maria Nikoghosyan, Siras Hakobyan, Anahit Hovhannisyan, Henry Loeffler-Wirth, Hans Binder & Arsen Arakelyan. (2019) Population Levels Assessment of the Distribution of Disease-Associated Variants With Emphasis on Armenians – A Machine Learning Approach. Frontiers in Genetics 10.
Crossref
Chelsie N. Berg, Neha Sinha & Mark A. Gluck. (2019) ABCA7 Risk Genotype Diminishes the Neuroprotective Value of Aerobic Fitness in Healthy Older African Americans. Frontiers in Aging Neuroscience 11.
Crossref
Jia Zhao, Mengxia Zhu, Mukesh Kumar, Fung Yin Ngo, Yinghui Li, Lixing Lao & Jianhui Rong. (2019) A Pharmacological Appraisal of Neuroprotective and Neurorestorative Flavonoids Against Neurodegenerative Diseases. CNS & Neurological Disorders - Drug Targets 18:2, pages 103-114.
Crossref
Jialing Fan, Wuhai Tao, Xin Li, He Li, Junying Zhang, Dongfeng Wei, Yaojing Chen & Zhanjun Zhang. (2019) The Contribution of Genetic Factors to Cognitive Impairment and Dementia: Apolipoprotein E Gene, Gene Interactions, and Polygenic Risk. International Journal of Molecular Sciences 20:5, pages 1177.
Crossref
Matthew O. Goodman, Lori Chibnik & Tianxi Cai. (2019) Variance components genetic association test for zero-inflated count outcomes. Genetic Epidemiology 43:1, pages 82-101.
Crossref
Hasan A.M.M. Almansoub, Hui Tang, Ying Wu, Ding-Qi Wang, Yacoubou Abdoul Razak Mahaman, Na Wei, Yusra A. M. Almansob, Wei He & Dan Liu. (2019) Tau Abnormalities and the Potential Therapy in Alzheimer’s Disease. Journal of Alzheimer's Disease 67:1, pages 13-33.
Crossref
Sonia Sharma, Paramjeet Kaur, Shallina Gupta & Sushant Sharma. 2019. Handbook of Research on Critical Examinations of Neurodegenerative Disorders. Handbook of Research on Critical Examinations of Neurodegenerative Disorders 102 128 .
Kelly Hares, Scott Miners, Neil Scolding, Seth Love & Alastair Wilkins. (2019) KIF5A and KLC1 expression in Alzheimer’s disease: relationship and genetic influences. AMRC Open Research 1, pages 1.
Crossref
Kelly Hares, Scott Miners, Neil Scolding, Seth Love & Alastair Wilkins. (2019) KIF5A and KLC1 expression in Alzheimer’s disease: relationship and genetic influences. AMRC Open Research 1, pages 1.
Crossref
Yannan Bin, Qizhi Zhu, Menglu Li & Junfeng Xia. (2019) Comprehensive Analysis of Alzheimer’s Disease Biologically Candidate Causal Genes Revealed by Function Association Study With GWAS. IEEE Access 7, pages 114236-114245.
Crossref
Haiqiang Ma, Ting Li, Hongtu Zhu & Zhongyi Zhu. (2019) Quantile regression for functional partially linear model in ultra-high dimensions. Computational Statistics & Data Analysis 129, pages 135-147.
Crossref
Emily H. Trittschuh & Lucy Wang. 2019. Physician's Field Guide to Neuropsychology. Physician's Field Guide to Neuropsychology 209 221 .
Limin Ma, Jiewen Zhang, Yingying Shi, Wan Wang, Zhixia Ren, Mingrong Xia, Yuanxing Zhang & Miaomiao Yang. (2018) Gene mutations in a Han Chinese Alzheimer's disease cohort. Brain and Behavior 9:1.
Crossref
Idoia Blanco-Luquin, Miren Altuna, Javier Sánchez-Ruiz de Gordoa, Amaya Urdánoz-Casado, Miren Roldán, María Cámara, Victoria Zelaya, María Elena Erro, Carmen Echavarri & Maite Mendioroz. (2018) PLD3 epigenetic changes in the hippocampus of Alzheimer’s disease. Clinical Epigenetics 10:1.
Crossref
Tao Tan, Lin Xia, Kailing Tu, Jie Tang, Senlin Yin, Lunzhi Dai, Peng Lei, Biao Dong, Hongbo Hu, Yong Fan, Yang Yu & Dan Xie. (2018) Improved Macaca fascicularis gene annotation reveals evolution of gene expression profiles in multiple tissues. BMC Genomics 19:1.
Crossref
Ya. V. Gorina, O. L. Lopatina, Yu. K. Komleva, A. I. Chernykh & A. B. Salmina. (2019) Expression of MAPK and Inflammasomes in Brain Cells in Experimental Alzheimer’s Disease. Human Physiology 44:8, pages 906-911.
Crossref
Kevin Mullane & Michael Williams. (2018) Alzheimer’s disease (AD) therapeutics – 2: Beyond amyloid – Re-defining AD and its causality to discover effective therapeutics. Biochemical Pharmacology 158, pages 376-401.
Crossref
Can Ilgın & Ahmet Topuzoğlu. (2018) Extracellular Vesicles in Psychiatry Research in the Context of RDoC Criteria. Psychiatry Investigation 15:11, pages 1011-1018.
Crossref
Gary P. Morris, Ian A. Clark & Bryce Vissel. (2018) Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer’s disease. Acta Neuropathologica 136:5, pages 663-689.
Crossref
Mark A. McCormickDaniel E.L. Promislow. (2018) Recent Advances in the Systems Biology of Aging. Antioxidants & Redox Signaling 29:10, pages 973-984.
Crossref
Giulia M. Sancesario & Sergio Bernardini. (2018) Alzheimer's disease in the omics era. Clinical Biochemistry 59, pages 9-16.
Crossref
Chao Wang & William E. Balch. (2018) Bridging Genomics to Phenomics at Atomic Resolution through Variation Spatial Profiling. Cell Reports 24:8, pages 2013-2028.e6.
Crossref
Mubashir Hassan, Saba Shahzadi, Hany Alashwal, Nazar Zaki, Sung-Yum Seo & Ahmed A. Moustafa. (2018) Exploring the mechanistic insights of Cas scaffolding protein family member 4 with protein tyrosine kinase 2 in Alzheimer’s disease by evaluating protein interactions through molecular docking and dynamic simulations. Neurological Sciences 39:8, pages 1361-1374.
Crossref
Fabrizio Vecchio, Francesca Miraglia, Francesco Iberite, Giordano Lacidogna, Valeria Guglielmi, Camillo Marra, Patrizio Pasqualetti, Francesco Danilo Tiziano & Paolo Maria Rossini. (2018) Sustainable method for Alzheimer dementia prediction in mild cognitive impairment: Electroencephalographic connectivity and graph theory combined with apolipoprotein E. Annals of Neurology 84:2, pages 302-314.
Crossref
Carla Nieto, María Cornago, María Cabildo, Dionisia Sanz, Rosa Claramunt, María Torralba, María Torres, Diana Martínez Casanova, Yaiza Sánchez-Alegre, Esther Escudero & José Lavandera. (2018) Evaluation of the Antioxidant and Neuroprotectant Activities of New Asymmetrical 1,3-Diketones. Molecules 23:8, pages 1837.
Crossref
Yun Freudenberg-Hua, Wentian Li & Peter Davies. (2018) The Role of Genetics in Advancing Precision Medicine for Alzheimer’s Disease—A Narrative Review. Frontiers in Medicine 5.
Crossref
Maya L. Gosztyla, Holly M. Brothers & Stephen R. Robinson. (2018) Alzheimer’s Amyloid-β is an Antimicrobial Peptide: A Review of the Evidence. Journal of Alzheimer's Disease 62:4, pages 1495-1506.
Crossref
Warren Winick-Ng & R. Jane Rylett. (2018) Into the Fourth Dimension: Dysregulation of Genome Architecture in Aging and Alzheimer’s Disease. Frontiers in Molecular Neuroscience 11.
Crossref
Devesh Tewari, Adrian M. Stankiewicz, Andrei Mocan, Archana N. Sah, Nikolay T. Tzvetkov, Lukasz Huminiecki, Jarosław O. Horbańczuk & Atanas G. Atanasov. (2018) Ethnopharmacological Approaches for Dementia Therapy and Significance of Natural Products and Herbal Drugs. Frontiers in Aging Neuroscience 10.
Crossref
Sultan Chaudhury, Tulsi Patel, Imelda S. Barber, Tamar Guetta-Baranes, Keeley J. Brookes, Sally Chappell, James Turton, Rita Guerreiro, Jose Bras, Dena Hernandez, Andrew Singleton, John Hardy, David Mann, Kevin Morgan, Peter Passmore, David Craig, Janet Johnston, Bernadette McGuinness, Stephen Todd, Reinhard Heun, Heike Kölsch, Patrick G. Kehoe, Emma R.L.C. Vardy, Nigel M. Hooper, Stuart Pickering-Brown, Julie Snowden, Anna Richardson, Matthew Jones, David Neary, Jennifer Harris, James Lowe, A. David Smith, Gordon Wilcock, Donald Warden & Clive Holmes. (2018) Polygenic risk score in postmortem diagnosed sporadic early-onset Alzheimer's disease. Neurobiology of Aging 62, pages 244.e1-244.e8.
Crossref
Qiong Ding, Kitora Tanigawa, Jun Kaneko, Mamoru Totsuka, Yoshinori Katakura, Etsuko Imabayashi, Hiroshi Matsuda & Tatsuhiro Hisatsune. (2018) Anserine/Carnosine Supplementation Preserves Blood Flow in the Prefrontal Brain of Elderly People Carrying APOE e4. Aging and disease 9:3, pages 334.
Crossref
Feng Bai, Chunming Xie, Yonggui Yuan, Yongmei Shi & Zhijun Zhang. (2018) Promoter haplotypes of interleukin-10 gene linked to cortex plasticity in subjects with risk of Alzheimer's disease. NeuroImage: Clinical 17, pages 587-595.
Crossref
Puneet Sharma & Ilse S. Pienaar. 2018. Molecular-Genetic and Statistical Techniques for Behavioral and Neural Research. Molecular-Genetic and Statistical Techniques for Behavioral and Neural Research 565 596 .
Massimo S. Fiandaca, Mark Mapstone, Elenora Connors, Mireille Jacobson, Edwin S. Monuki, Shaista Malik, Fabio Macciardi & Howard J. Federoff. (2017) Systems healthcare: a holistic paradigm for tomorrow. BMC Systems Biology 11:1.
Crossref
M. Maitre, C. Klein & A.G. Mensah-Nyagan. (2017) Mécanismes, facteurs de risque et stratégies thérapeutiques dans la maladie d’Alzheimer. NPG Neurologie - Psychiatrie - Gériatrie 17:102, pages 352-364.
Crossref
Ágnes Kasza, Botond Penke, Zsuzsanna Frank, Zsolt Bozsó, Viktor Szegedi, Ákos Hunya, Klaudia Németh, Gábor Kozma & Lívia Fülöp. (2017) Studies for Improving a Rat Model of Alzheimer’s Disease: Icv Administration of Well-Characterized β-Amyloid 1-42 Oligomers Induce Dysfunction in Spatial Memory. Molecules 22:11, pages 2007.
Crossref
Rita Khoury, Kush Patel, Jake Gold, Stephanie Hinds & George T. Grossberg. (2017) Recent Progress in the Pharmacotherapy of Alzheimer’s Disease. Drugs & Aging 34:11, pages 811-820.
Crossref
Jerome Robert, Emily B Button, Brian Yuen, Megan Gilmour, Kevin Kang, Arvin Bahrabadi, Sophie Stukas, Wenchen Zhao, Iva Kulic & Cheryl L Wellington. (2017) Clearance of beta-amyloid is facilitated by apolipoprotein E and circulating high-density lipoproteins in bioengineered human vessels. eLife 6.
Crossref
Botond Penke, Ferenc Bogár & Lívia Fülöp. (2017) β-Amyloid and the Pathomechanisms of Alzheimer’s Disease: A Comprehensive View. Molecules 22:10, pages 1692.
Crossref
Marissa A. Tafoya, Saaussan Madi & Laurel O. Sillerud. (2017) Superparamagnetic nanoparticle-enhanced MRI of Alzheimer's disease plaques and activated microglia in 3X transgenic mouse brains: Contrast optimization. Journal of Magnetic Resonance Imaging 46:2, pages 574-588.
Crossref
Manuela Pennisi, Rosalia Crupi, Rosanna Di Paola, Maria Laura Ontario, Rita Bella, Edward J. Calabrese, Roberto Crea, Salvatore Cuzzocrea & Vittorio Calabrese. (2016) Inflammasomes, hormesis, and antioxidants in neuroinflammation: Role of NRLP3 in Alzheimer disease. Journal of Neuroscience Research 95:7, pages 1360-1372.
Crossref
Walter Gulisano, Antonella Bizzoca, Gianfranco Gennarini, Agostino Palmeri & Daniela Puzzo. (2017) Role of the adhesion molecule F3/Contactin in synaptic plasticity and memory. Molecular and Cellular Neuroscience 81, pages 64-71.
Crossref
David O. Arnar & Runolfur Palsson. (2017) Genetics of common complex diseases: a view from Iceland. European Journal of Internal Medicine 41, pages 3-9.
Crossref
Dong Hee Kim, Jeong-An Gim, Anshuman Mishra, Kyeongjun Lee, Youngseuk Cho & Heui-Soo Kim. (2017) SNP analysis of genes related to cholesterol metabolism and associated with late-onset Alzheimer’s disease. Genes & Genomics 39:6, pages 593-600.
Crossref
Leah Zuroff, David Daley, Keith L. Black & Maya Koronyo-Hamaoui. (2017) Clearance of cerebral Aβ in Alzheimer’s disease: reassessing the role of microglia and monocytes. Cellular and Molecular Life Sciences 74:12, pages 2167-2201.
Crossref
Suzanne Hood & Shimon AmirAmirAmir. (2017) Neurodegeneration and the Circadian Clock. Frontiers in Aging Neuroscience 9.
Crossref
Sapeck Agrawal. (2017) Genetics of Alzheimer’s Disease and Research Models. Materials and Methods 7.
Crossref
Inmaculada Ayala & Antonino Colanzi. (2017) Alterations of Golgi organization in Alzheimer’s disease: A cause or a consequence?. Tissue and Cell 49:2, pages 133-140.
Crossref
Jussi Paananen. (2017) Bioinformatics in the Identification of Novel Targets and Pathways in Neurodegenerative Diseases. Current Genetic Medicine Reports 5:1, pages 15-21.
Crossref
F. Philip, E.E. Ha, M.A. Seeliger & M.A. Frohman. 2017. Enzymology at the Membrane Interface: Interfacial Enzymology and Protein-Membrane Binding. Enzymology at the Membrane Interface: Interfacial Enzymology and Protein-Membrane Binding 309 325 .
Elísabet Alcocer-Gómez, Beatriz Castejón-Vega & Mario D. Cordero. 2017. Stress and Inflammation in Disorders. Stress and Inflammation in Disorders 127 162 .
Renã A. S. Robinson, Bushra Amin & Paul C. Guest. 2017. Proteomic Methods in Neuropsychiatric Research. Proteomic Methods in Neuropsychiatric Research 21 48 .
Wang Kezhu, Xu Pan, Lu Cong, Dong Liming, Zhang Beiyue, Lu Jingwei, Yang Yanyan & Liu Xinmin. (2017) Effects of Ginsenoside Rg1 on Learning and Memory in a Reward-directed Instrumental Conditioning Task in Chronic Restraint Stressed Rats. Phytotherapy Research 31:1, pages 81-89.
Crossref
Jan Aaseth, Jan Alexander, Geir Bjørklund, Knut Hestad, Petr Dusek, Per M. Roos & Urban Alehagen. (2016) Treatment strategies in Alzheimer’s disease: a review with focus on selenium supplementation. BioMetals 29:5, pages 827-839.
Crossref